Valproate Sodium Injection
Product Images NDC 0143-9785

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valproate Sodium (NDC 0143-9785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Valproate Sodium Injection 1)

FDA Label Image

Figure 1 (Valproate Sodium Injection 2)

This text appears to be a graph or chart showing the reduction in CPS rate of patients treated with Divalproo Sodium versus a placebo. The graph shows a 50% reduction in CPS rate for the group of patients treated with Divalproo Sodium compared to the placebo group. The graph also includes categories for improvement, no change, and worsening.*

FDA Label Image

Figure 2 (Valproate Sodium Injection 3)

FDA Label Image

Ndc 0143-9785-01 Valproate Sodium Injection, Usp 500 mg/5 mL (100 mg/ml) For Iv Infusion Only Rx Only 5 mL Single Dose Vial Each mL Contains: Valproic Acid 100 mg, Edetate Disodium 0.4 mg, And Water For Injection. Ph Adjusted With Sodium Hydroxide And/or Hydrochloric Acid. Usual Dosage: See Package Insert. Contains No Preservatives Discard Any Unused Solution. Store At 20º To 25ºc (68º To 77ºf) [see Usp Controlled Room Temperature]. (Valproate Sodium Injection 4)

NDC 0143-9785-01 is a Sodium Injection, USP with a strength of 500 mg per 5 mL (100 mg/mL). This is a preservative-free intravenous infusion medication in a single-dose vial. Each mL contains 100 mg of valproic acid, 0.4 mg of edetate disodium, and water for injection. The pH is adjusted with sodium hydroxide and/or hydrochloric acid. The manufacturer is HIKMA FARMACEUTICA (PORTUGAL), S.A. and it is distributed by Hikma Pharmaceuticals USA Inc. This medication should be stored at 20°to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. There is no information available on the Lot number provided.*

FDA Label Image

Plb782-wes/2 (Valproate Sodium Injection 5)

This is the description of a medicine called Valproate Sodium Injection, USP. The injection comes in 500 mg per 5 mL (100 mg/mL) preservative-free 105L single dose vials, and is intended for intravenous infusion only. The prescription is necessary, and the usual dosage and package insert should be followed. The product is stored between 20° and 25°C (68 to 77°F), and is distributed by Hikma.*

FDA Label Image

Valproate Sodium Injection 6

This is a product identification code that contains a 14-digit GTIN (Global Trade Item Number), a 13-digit serial number (SN), and an expiration date listed as MMMYYYY (month and year). Additionally, there is a lot number listed as ABCDE12345.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.